Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Operating Leases (2019 - 2026)

Vericel (VCEL) posted Operating Leases of $93.1 million for Q2 2026, down 2.01% sequentially from $95.0 million in Q1 2026, and down 7.27% YoY from $100.4 million in Q2 2025.

Analysis

Vericel (VCEL) Operating Leases (2019 - 2026) Analysis & Trends

Vericel has reported Operating Leases for 8 years, with the latest figure at $93.1 million in Q2 2026.

  • Quarterly Operating Leases fell 7.27% year-over-year to $93.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $93.1 million (down 7.27% YoY) and the FY2025 annual result came in at $96.9 million, down 2.66% from the prior year.
  • Operating Leases eased to $93.1 million in Q2 2026 per VCEL's latest filing, from $95.0 million in the prior quarter.
  • Over five years, Operating Leases peaked at $100.4 million in Q2 2025 and troughed at $46.1 million in Q1 2022.
  • A 5-year average of $81.2 million and a median of $92.6 million in 2024 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2024 and 2026: Operating Leases surged 96.56% in 2024, then decreased 7.27% in 2026.
  • Over 5 years, Operating Leases stood at $47.6 million in 2022, then jumped by 84.92% to $88.0 million in 2023, then rose by 13.05% to $99.5 million in 2024, then declined by 2.66% to $96.9 million in 2025, then retreated by 3.88% to $93.1 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $93.1 million, $95.0 million, and $96.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.13 Mn
Mar 31, 2026 95.04 Mn
Dec 31, 2025 96.89 Mn
Sep 30, 2025 98.67 Mn
Jun 30, 2025 100.44 Mn
Mar 31, 2025 99.65 Mn
Dec 31, 2024 99.54 Mn
Sep 30, 2024 97.46 Mn
Jun 30, 2024 95.59 Mn
Mar 31, 2024 92.15 Mn
Dec 31, 2023 88.04 Mn
Sep 30, 2023 85.00 Mn
Jun 30, 2023 83.38 Mn
Mar 31, 2023 46.88 Mn
Dec 31, 2022 47.61 Mn
Sep 30, 2022 48.12 Mn
Jun 30, 2022 48.18 Mn
Mar 31, 2022 46.07 Mn
Dec 31, 2021 50.18 Mn
Sep 30, 2021 48.54 Mn